Q&A: non-endoscopic detection for BE, esophageal adenocarcinoma

Q&A: non-endoscopic detection for BE, esophageal adenocarcinoma

Progress in the non-endoscopic detection for Barrett’s esophagus may lead to increased identification of those at risk for esophageal adenocarcinoma, according to opinions published in Annals of Internal Medicine.The American Cancer Society reports that esophageal adenocarcinoma (EAC) is a lethal form of cancer estimated to result in 15,530 deaths this year. While endoscopic screening followed by treatment for dysplasia can reduce the risk for BE progression to EAC, 90% of patients with EAC continue to be diagnosed outside of screening despite the presence of BE in 60% of EACs atRead More

Share on facebook
Share on twitter
Share on linkedin